Intravenous adenosine reduces myocardial no-reflow by decreasing endothelin-1 via activation of the ATP-sensitive K+ channel. [electronic resource]
Producer: 20080828Description: 355-9 p. digitalISSN:- 0001-5385
- Adenosine -- administration & dosage
- Animals
- Coronary Circulation -- drug effects
- Disease Models, Animal
- Echocardiography
- Endothelin-1 -- blood
- Injections, Intravenous
- KATP Channels -- drug effects
- Myocardial Infarction -- diagnosis
- Myocardial Reperfusion Injury -- diagnosis
- Myocardium -- metabolism
- Radioimmunoassay
- Random Allocation
- Swine
- Swine, Miniature
- Treatment Outcome
- Vasodilator Agents -- administration & dosage
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.